WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Autoneuron
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brinton, R. E.
Right arrow Articles by McEwen, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brinton, R. E.
Right arrow Articles by McEwen, B. S.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 9, 752-759, Copyright © 1989 by Society for Neuroscience

ARTICLE

Vasopressin neuromodulation in the hippocampus

RE Brinton and BS McEwen
Laboratory of Neuroendocrinology, Rockefeller University, New York, New York 10021.

This study explored an effector mechanism associated with the arginine vasopressin (AVP) recognition site in the hippocampus, namely, potentiation of norepinephrine (NE)-induced cAMP accumulation in the surviving hippocampal slice. The biochemical mechanisms that underlie the AVP potentiation were investigated as follows: First, the actions of AVP upon NE-induced accumulation of cAMP in hippocampal slices from rat brain were specific to AVP and not shared by other closely related peptides, namely, oxytocin and AVP4-9. Second, the AVP-induced neuromodulation involved beta-adrenergic receptors, with AVP having no effect on cAMP levels in the absence of NE. Third, the potentiation by AVP was biphasic, with lower AVP concentrations potentiating NE-induced cAMP accumulation, while higher concentrations did not potentiate. Fourth, an antagonist of V1-type AVP receptors blocked AVP potentiation. Fifth, AVP potentiation was dependent upon extracellular calcium concentrations. Sixth, AVP potentiation was blocked by 50 microM trifluoperazine, which is consistent with a calcium-calmodulin involvement but which might also implicate protein kinase C. These alternatives and the nature of the calcium involvement are discussed. AVP actions thus appear to involve interactions between several second- messenger systems and suggest a biochemical mechanism by which AVP exerts its centrally mediated behavioral effects.


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
S. Frey, J. Bergado-Rosado, T. Seidenbecher, H.-C. Pape, and J. U. Frey
Reinforcement of Early Long-Term Potentiation (Early-LTP) in Dentate Gyrus by Stimulation of the Basolateral Amygdala: Heterosynaptic Induction Mechanisms of Late-LTP
J. Neurosci., May 15, 2001; 21(10): 3697 - 3703.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Omura, J. Nabekura, and N. Akaike
Intracellular Pathways of V1 and V2 Receptors Activated by Arginine Vasopressin in Rat Hippocampal Neurons
J. Biol. Chem., November 12, 1999; 274(46): 32762 - 32770.
[Abstract] [Full Text] [PDF]


-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-